Table 4.
Characteristics | ASA class 1/2 | ASA class 3/4 | P-value |
---|---|---|---|
Patients | 16 | 23 | - |
Demographics | |||
Age (years)∗ | 46.5 ± 22.3 | 59.1 ± 17.5 | 0.056 |
BMI (kg/m2)∗ | 24.75 ± 5.5 | 28.35 ± 9.46 | 0.193 |
Race/ethnicity | 0.420 | ||
Caucasian | 3 (18.8%) | 3 (13%) | |
African American | 1 (6.3%) | 4 (17.4%) | |
Hispanic/Latinx | 10 (62.5%) | 8 (34.8%) | |
Asian | 0 | 0 | |
Other/not reported | 2 (12.5%) | 8 (34.8%) | |
Comorbidities | |||
Tobacco use | |||
Active | 2 (14.3%) | 1 (5%) | 0.555 |
Former | 0 | 5 (25%) | 0.063 |
Hypertension | 4 (25%) | 14 (60.9%) | 0.049 |
Congestive heart failure | 0 | 3 (13%) | 0.255 |
Coronary artery disease | 0 | 5 (21.7%) | 0.066 |
Cerebrovascular accident | 0 | 2 (8.7%) | 0.503 |
COPD | 0 | 5 (21.7%) | 0.066 |
Diabetes mellitus | 1 (6.3%) | 3 (13%) | 0.631 |
Chronic kidney disease | 0 | 5 (21.7%) | 0.066 |
Hemodialysis | 0 | 4 (17.4%) | 0.130 |
Preoperative clinical course | |||
Any preoperative COVID-19 symptoms | 8 (50%) | 12 (52.2%) | 0.894 |
Preoperative positive COVID-19 test | 12 (75%) | 10 (43.5%) | 0.099 |
Preoperative admission for COVID-19 | 0 | 3 (13%) | 0.255 |
Time from symptom onset to surgery (days)∗ | 15.3 ± 4.5 | 17.7 ± 6.4 | 0.666 |
Time from positive COVID-19 test to surgery (days)∗ | 0.3 ± 8.5 | 4 ± 14 | 0.358 |
Surgical outcomes | |||
Procedure length (mins)∗ | 171.3 ± 99 | 181.5 ± 127.1 | 0.789 |
COVID-related inability to extubate in OR | 1 (6.3%) | 2 (8.7%) | 1.000 |
New postoperative COVID-related ICU requirement | 2 (12.5%) | 5 (21.7%) | 0.678 |
Postoperative ICU length of stay (days)∗ | 6 ± 5.7 | 8.1 ± 4.0 | 0.667 |
Intubation | 1 (6.3%) | 4 (18.2%) | 0.374 |
Days on ventilator∗ | 10† | 10.3 ± 3.8 | 1.000 |
Hospital length of stay (days)∗ | 6.6 ± 6.7 | 30.8 ± 34.3 | 0.008 |
Remain admitted to hospital | 2 (12.5%) | 7 (30.4%) | 0.262 |
Deceased | 0 | 4 (17.4%) | 0.130 |
Bold indicates P < 0.05.
ASA = American Society of Anesthesiologists.
Mean ± Standard Deviation.
Only 1 patient in ASA class 1/2 placed on ventilator postoperatively.